𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994–2007

✍ Scribed by Shelley Day; Kofi Acquah; Paul P. Lee; Prithvi Mruthyunjaya; Frank A. Sloan

Book ID
116203048
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
222 KB
Volume
152
Category
Article
ISSN
0002-9394

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ranibizumab for Neovascular Age-Related
Ranibizumab for Neovascular Age-Related Macular Degeneration
✍ Rosenfeld, Philip J.; Brown, David M.; Heier, Jeffrey S.; Boyer, David S.; Kaise 📂 Article 📅 2006 🏛 Massachusetts Medical Society 🌐 English ⚖ 299 KB

## Background: Ranibizumab--a recombinant, humanized, monoclonal antibody fab that neutralizes all active forms of vascular endothelial growth factor a--has been evaluated for the treatment of neovascular age-related macular degeneration. ## Methods: In this multicenter, 2-year, double-blind, sha